Junfeng Du

机构：Chinese PLA General Hospital, Shaoxing People's Hospital · ORCID：0000-0002-8482-4271

发表论文 76 篇 · 总被引 1999 次 · h-index 20

代表论文

• Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond (2023 · Frontiers in Immunology · 被引 110)
• Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer (2022 · Frontiers in Immunology · 被引 65)
• Tertiary lymphoid structures predict survival and response to neoadjuvant therapy in locally advanced rectal cancer (2024 · npj Precision Oncology · 被引 43)
• How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translation (2023 · International Journal of Cancer · 被引 27)
• Targeting intratumor heterogeneity suppresses colorectal cancer chemoresistance and metastasis (2023 · EMBO Reports · 被引 26)
• The emerging role of neutrophil extracellular traps in cancer: from lab to ward (2023 · Frontiers in Oncology · 被引 21)